Rubella IgG is an antibody your immune system produces in response to rubella virus, either from a past infection or from vaccination. When a lab report shows a rubella IgG result, it is telling you whether your blood contains these antibodies and, by extension, whether you have immune protection against rubella. Most people encounter this test during routine prenatal screening or pre-employment health checks, and the result typically falls into one of three buckets: positive (immune), negative (not immune), or equivocal (borderline). But what those categories actually mean for you depends on context, and the test itself has more nuance than most people realize.
What the Test Actually Measures
Rubella IgG belongs to the immunoglobulin G class of antibodies, the most abundant type circulating in your blood. Your body starts producing rubella-specific IgG a couple of weeks after exposure to the virus or after receiving the MMR (measles, mumps, rubella) vaccine. Unlike IgM antibodies, which spike early during an acute infection and then fade relatively quickly, IgG antibodies persist for years or even decades. Their presence is the main marker labs use to determine whether you’ve built lasting immunity.
Commercial lab assays measure rubella IgG in international units per milliliter (IU/ml), calibrated against a World Health Organization international standard. Results at or above 10 IU/ml are generally reported as positive, meaning you have enough antibodies to be considered immune. Results below that threshold are negative, and results hovering near the cutoff land in the equivocal zone. That said, these cutoffs are not as precise as they look on paper. A large investigation into the performance of commercial rubella IgG assays found that when the cutoff was set at 10 IU/ml, sensitivity ranged from about 70% to 91% and specificity from about 66% to 100%, depending on the assay used.1PubMed Central. Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays That is a surprisingly wide spread for a test that produces a single number and a neat “immune” or “not immune” label.
Why Different Assays Can Give Different Answers
One reason for that variation is a standardization problem that has dogged rubella testing for years. The WHO international standard used to calibrate these assays is made from pooled human immunoglobulin rather than a purified single analyte, and it was originally calibrated using older, now-superseded testing methods. No formal measurement uncertainty estimates were provided when it was established. A detailed analysis of these issues concluded that the standard fails on multiple core metrological principles, which means two different commercial assays can give meaningfully different IU/ml values for the same blood sample.2PubMed Central. Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies
In practical terms, this means that a result of 8 IU/ml on one platform might register as 12 IU/ml on another. If your result is borderline, the specific brand of assay your lab uses genuinely matters. This is worth knowing if you have been told your rubella immunity is “equivocal” and are retested at a different lab: a shift from equivocal to positive (or vice versa) could reflect assay differences rather than a real change in your immune status.
Positive Result
A positive rubella IgG result means your blood contains antibodies above the protective threshold. In most situations, this is all you need to know: you have immunity, whether from vaccination or from a past rubella infection you may not even remember having. The vast majority of adults in countries with high MMR vaccination coverage will test positive.
One thing a standard IgG test does not tell you is how you acquired that immunity or how recently. If a doctor needs that information, they can order additional tests. The distinction between “immune from years ago” and “immune because of a very recent infection” matters in pregnancy, which is the scenario where most people find themselves scrutinizing these results closely.
Negative or Equivocal Result
A negative result means your antibody level is below the accepted cutoff for protection. If you are not pregnant and not planning a pregnancy, the usual recommendation is straightforward: get vaccinated (or re-vaccinated) with MMR. After vaccination, a follow-up blood test is typically done about three to four weeks later to confirm that your antibody levels have risen above the cutoff.3PubMed Central. Immunity to rubella: an Italian retrospective cohort study If the level is still negative after a first booster, a second dose can be given and tested again.
An equivocal result is more ambiguous. You have some antibody, but not clearly enough to call it protective. Given the assay variability discussed above, an equivocal result on one test might be clearly positive on another. Your doctor may repeat the test, use a different assay, or simply recommend vaccination to push your levels above any reasonable cutoff. For people who are not pregnant, vaccination is low-risk and resolves the uncertainty.
Why This Test Gets Ordered During Pregnancy
Rubella IgG screening is a standard part of prenatal care in many countries. The reason is congenital rubella syndrome (CRS), a set of severe birth defects that can occur when a pregnant person contracts rubella, especially during the first trimester. CRS can cause heart defects, cataracts, hearing loss, and neurological problems, and rubella infection early in pregnancy can also lead to miscarriage or stillbirth.4PubMed. Maternal exposure to rubella infection elevates risk of congenital rubella syndrome (CRS) A case report documented a newborn with CRS presenting with microcephaly, heart defects including patent ductus arteriosus and atrial septal defect, congenital cataracts, cleft palate, and abnormal hearing, illustrating just how wide-ranging the damage can be.5Journal of Pediatric Neurology. Congenital Rubella Syndrome: Clinical and Imaging Features
Screening guidelines recommend checking rubella immune status in pregnant people who have no record of prior immunity and no documentation of rubella vaccination.6Journal of Obstetrics and Gynaecology Canada. Rubella in Pregnancy The risk of CRS drops substantially after the first 20 weeks of pregnancy, but the stakes in early pregnancy are high enough that knowing your rubella IgG status before or at the start of pregnancy is genuinely important.4PubMed. Maternal exposure to rubella infection elevates risk of congenital rubella syndrome (CRS)
If you are already pregnant and your rubella IgG comes back negative, the situation is frustrating: MMR is a live vaccine and is not given during pregnancy. The standard advice is to avoid anyone with a known rubella infection, get vaccinated immediately after delivery, and avoid becoming pregnant again for at least one month after vaccination. Older guidelines recommended a three-month wait, and one study from the early 1980s confirmed that seronegative women who were vaccinated postpartum did follow that instruction.7PubMed Central. Is post partum rubella vaccination worthwhile? Current guidance from most agencies has since shortened the recommended waiting period.
Can You Lose Immunity Over Time?
Yes, though the decline is usually gradual. A study tracking rubella-specific IgG, neutralizing antibodies, and memory B cell responses over time found that all three declined with increasing time since vaccination, but described the decreases as “relatively moderate.”8PubMed Central. Durability of Humoral Immune Responses to Rubella Following MMR Vaccination Most vaccinated people retain measurable IgG for decades, but a small fraction do not. In a study of nearly 700 young adults roughly 15 years after their second MMR dose, about 1.8% had rubella antibody levels below 10 U/ml. After receiving a third dose of MMR, their average titers jumped to over 18 times their pre-vaccination level, and 92% of those with initially low titers seroconverted. The boost was most dramatic in people who had the lowest starting levels, though titers declined somewhat over the following year while remaining well above where they started.9PubMed. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults
This means that a negative rubella IgG result in a previously vaccinated adult does not necessarily mean vaccination “didn’t work.” It can mean that antibody levels have slowly waned below the detection threshold over many years. A booster dose usually fixes the problem quickly, which is reassuring if you find yourself in this situation during pre-pregnancy planning.
Vaccinated People Who Still Test Negative
It is worth flagging that some vaccinated populations have higher rates of seronegativity than you might expect. A study of over 12,000 pregnant women found that those born after 1983, who grew up under a two-dose rubella vaccination schedule, actually had higher rates of rubella seronegativity (about 9%) compared to women born in or before 1983 (about 4%). Birth after 1983 was independently associated with roughly double the odds of being seronegative.10PLoS One. Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger
That may sound paradoxical. The likely explanation is that older cohorts were more likely to have encountered wild rubella virus circulating in the community, which provides a natural immune boost on top of vaccination. Younger cohorts who grew up after rubella was largely eliminated through vaccination may have gotten their shots, mounted an initial response, and then had no viral exposure to reinforce it. The result is a slow drift toward undetectable IgG levels in a meaningful minority. This is one of the quirks of vaccine success: by virtually eliminating the pathogen, you also eliminate the natural boosting that kept immunity topped up in previous generations.
IgG Avidity and What It Tells Doctors
When a pregnant person tests positive for both rubella IgG and IgM (the acute-phase antibody), doctors face a problem: does this mean a recent, potentially dangerous primary infection, or is it something less concerning, like a reinfection or just lingering IgM from vaccination? This is where IgG avidity testing becomes valuable. Avidity measures how strongly the IgG antibodies bind to the rubella virus. Early in an immune response, the body produces IgG that binds loosely (low avidity). Over weeks and months, the immune system refines those antibodies so they bind more tightly (high avidity).
In primary rubella infection, the shift from low avidity (below about 30%) to high avidity happens over roughly four weeks after the rash appears. After vaccination, the increase is slower, reaching a useful high-avidity threshold at around two and a half months.11PubMed. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection Research has confirmed that the humoral immune response differs between primary infection and vaccination, which is why avidity patterns after each follow different timelines.12PubMed Central. Humoral immune response after primary rubella virus infection and after vaccination
A high avidity result in the setting of a positive IgG and positive IgM essentially rules out a recent primary infection. The antibodies have had time to mature, so the infection (or vaccination) happened months to years ago. This is a relief during pregnancy, because it means the fetus was not exposed during the risky window. IgG avidity has been described as a proven supplementary tool for distinguishing reinfection or persistent virus from a new primary exposure.13PubMed Central. Significance of IgG-Avidity in Antenatal Rubella Diagnosis
False Positives and Interference
Rubella IgM testing, which is often done alongside IgG, has a known vulnerability to interference from rheumatoid factor (RF), an IgM-class autoantibody found in people with rheumatoid arthritis and some other conditions. When RF is present in the blood, it can produce false-positive rubella IgM results in certain assays. The effect is most pronounced when rubella IgG titers are high but RF levels are only modestly elevated: in that combination, even a relatively low amount of RF can cause interference. The false-positive IgM titers generated this way tend to be low, but they are enough to trigger unnecessary alarm if the result is not interpreted carefully.14PubMed Central. IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies
This is another reason avidity testing matters. If IgM comes back positive but IgG avidity is high, the IgM result is almost certainly a false alarm or reflects something other than a dangerous new infection. Doctors who work with rubella serology are generally aware of this pitfall, but it is worth knowing so you can ask the right questions if you find yourself facing a confusing combination of results during pregnancy.
Rubella IgG in Newborns and Infants
If your newborn has a blood test that shows positive rubella IgG, it does not mean the baby has been infected or vaccinated. Rubella IgG crosses the placenta during pregnancy, so babies are born with their mother’s antibodies. In fact, antibody levels in term newborns tend to be slightly higher than in their mothers, with cord blood to maternal ratios averaging about 1.2 to 1 for rubella.15PubMed. Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization
These borrowed antibodies do not last. Concentrations drop rapidly in the first six months of life, and rubella seropositivity reaches its lowest point around 12 to 15 months of age, when only about 2% of infants still have detectable antibody.16PubMed Central. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses A longitudinal study following over 200 mother-infant pairs estimated the mean duration of passive rubella immunity at roughly two months.17PubMed. Kinetics of maternal antibodies against rubella and varicella in infants This is why the first dose of MMR vaccine is typically given around 12 months: by then, maternal antibodies have cleared enough that the vaccine can stimulate the baby’s own immune system without being neutralized by leftover maternal IgG.
Checking Your Own Status
Outside of pregnancy, there are good reasons to know your rubella IgG status. Healthcare workers, laboratory staff, and people who travel to regions where rubella still circulates are often required to document immunity. Some adults who grew up before universal vaccination, or who received only one dose, may have uncertain immune status. A Japanese survey found that fewer than a quarter of men and fewer than 40% of women in their twenties to forties had taken any action to confirm their rubella immunity, despite a recent outbreak that disproportionately affected adult men in that age group.18PubMed Central. Factors associated with adults’ actions to confirm their own rubella immune status in Japan’s drive toward rubella elimination Awareness of congenital rubella syndrome and knowledge that immunity testing exists were among the strongest predictors of whether someone had actually gotten tested.
If you are unsure of your vaccination history and cannot locate records, a rubella IgG test is a simple blood draw that resolves the question. A positive result documents your immunity. A negative result tells you to get vaccinated. In either case, you end up with a clear answer and, if needed, a plan to close the gap before it matters.
When IgG Alone Is Not Enough
A standalone rubella IgG result works well for answering “am I immune?” It is not designed to diagnose an active rubella infection on its own. Diagnosing acute rubella requires looking at IgM levels, changes in IgG over paired samples drawn weeks apart, IgG avidity, or direct detection of the virus through molecular methods. If you are being tested because of possible rubella exposure rather than routine screening, your doctor will typically order a broader panel rather than relying on a single IgG value. The combination of IgG, IgM, and avidity paints a much more complete picture of where you stand immunologically, whether this is an old encounter your body remembers, a brand-new infection requiring urgent attention, or just noise from a quirky assay or interfering antibody.